Summary
According to a post on X by @NeuraPod, Neuralink has registered a new study, NCT07929792, on ClinicalTrials.gov. The listing describes recruiting up to 10 adults with severe arm and hand impairment from spinal cord injury, ALS or chronic ischemic stroke, who would use the N1 implant to control a cursor or virtual keyboard at up to five US sites. The post notes that this is a trial registration rather than a result, and that it is the first Neuralink study listed to include stroke survivors, a much larger patient group.
AI-assisted summary based on the listed source.
What happened
ClinicalTrials.gov lists NCT07929792 as recruiting up to 10 adults with severe arm and hand impairment from spinal cord injury, ALS or chronic ischemic stroke, who will use the N1 implant to control a cursor or virtual keyboard at up to five US sites. It is a trial registration, not a result, but it is the first...
Why it matters
For people with paralysis, the listing suggests Neuralink's N1 research may extend beyond spinal cord injury and ALS to stroke survivors, though it does not show how well the device works. Patients and families considering trial enrollment, and investors following brain-computer interface companies, should watch for enrollment updates and any published results from the study.
Signal Intelligence
Signal Strength 78%
Technical label WATCH
Public Interest 46
Category RESEARCH
Reader Depth TECHNICAL
Signal Strength reflects source quality, relevance, freshness and evidence. Public Interest helps organize discovery; it is not proof of truth.
Public Interest components
Recognizable Entity Score 51
Practical Impact Score 26
Novelty Interest Score 94
Consequence Score 22
Curiosity Score 0
Shareability Score 61
Why this is here
VQV surfaced this signal because it is recent, relevant to AI Coding Tools, connected to Scobleizer News Pulse (X).
